China National Accord Medicines Corp Ltd (000028) — Cash Flow Reinvestment Rate
China National Accord Medicines Corp Ltd (000028) has a Cash Flow Reinvestment Rate of 0.05x as of June 2025, reinvesting CN¥95.44 Million (capex CN¥50.09 Million plus investments CN¥45.35 Million) from operating cash flow of CN¥1.83 Billion. Explore 000028 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for China National Accord Medicines Corp Ltd across 26 annual periods. Also explore 000028 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year capital reinvestment analysis for China National Accord Medicines Corp Ltd. For live market cap and broader valuation context, see China National Accord Medicines Corp Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | CN¥476.87 Million | CN¥3.27 Billion | CN¥282.70 Million | ▼ -6.4% |
| 2023 | 0.16x | CN¥457.64 Million | CN¥2.94 Billion | CN¥322.21 Million | ▼ -40.0% |
| 2022 | 0.26x | CN¥665.01 Million | CN¥2.56 Billion | CN¥322.19 Million | ▼ -16.4% |
| 2021 | 0.31x | CN¥514.46 Million | CN¥1.66 Billion | CN¥370.43 Million | ▲ +43.8% |
| 2020 | 0.22x | CN¥324.92 Million | CN¥1.50 Billion | CN¥293.83 Million | ▲ +43.6% |
| 2019 | 0.15x | CN¥301.17 Million | CN¥2.00 Billion | CN¥245.17 Million | ▼ -47.6% |
| 2018 | 0.29x | CN¥380.06 Million | CN¥1.32 Billion | CN¥255.48 Million | ▲ +70.1% |
| 2017 | 0.17x | CN¥217.09 Million | CN¥1.29 Billion | CN¥204.35 Million | ▼ -9.6% |
| 2016 | 0.19x | CN¥275.02 Million | CN¥1.47 Billion | CN¥265.89 Million | ▼ -13.7% |
| 2015 | 0.22x | CN¥226.73 Million | CN¥1.05 Billion | CN¥190.36 Million | ▼ -33.1% |
| 2013 | 0.32x | CN¥150.50 Million | CN¥465.03 Million | CN¥150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | CN¥193.57 Million | CN¥323.96 Million | CN¥193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | CN¥198.97 Million | CN¥227.32 Million | CN¥198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | CN¥177.99 Million | CN¥428.16 Million | CN¥177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | CN¥102.94 Million | CN¥270.85 Million | CN¥102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | CN¥84.98 Million | CN¥246.58 Million | CN¥84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | CN¥71.41 Million | CN¥87.70 Million | CN¥71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | CN¥118.22 Million | CN¥181.73 Million | CN¥118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | CN¥50.62 Million | CN¥148.28 Million | CN¥50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | CN¥14.18 Million | CN¥130.30 Million | CN¥14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | CN¥49.36 Million | CN¥81.22 Million | CN¥49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | CN¥26.90 Million | CN¥28.76 Million | CN¥26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | CN¥35.91 Million | CN¥71.16 Million | CN¥35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | CN¥21.01 Million | CN¥8.52 Million | CN¥21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | CN¥27.54 Million | CN¥22.84 Million | CN¥27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | CN¥10.38 Million | CN¥5.21 Million | CN¥10.38 Million | — |